Anybody have thoughts on how to capitalize on the WHO aspartame announcement? My gut is that it won't affect consumer behavior one bit, but I'm willing to put some money on the opposite.
I was thinking that Celanese could be a good bet. There has been some recent hype around it and, although it's a big conglomerate (the farthest thing from a pure play), I think it owns Sunett which is one of the more recognized acesulfame-K brands.
But more generally I'm interested in whether y'all know more about how to bet on acesulfame-K. I think most of the patents have expired so there may not be a good way if I want to stick with US equities. But you tell me.
Disclosures: Outside of non-sector-specific indexes, I don't own any sweetener or food/drink companies or anything else that seems related. I don't own Celanese.
Leave a Reply